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ABSTRACT This study describes a pilot clinical validation of a new low-cost system for the continuous
monitoring of the human body’s cardiorespiratory activities within the magnetic resonance examination area.
This study primarily focuses on monitoring cardiac activity and the related cardiac triggering. The patented
system tested by the authors is based on seismocardiography (SCG). The study was conducted on 18 subjects
on a Siemens Prisma 3TMR scanner. Standard anatomical and diffusion sequences were used to test cardiac
activity monitoring. A wide range of commonly used diagnostic sequences were used to test imaging of the
heart by means of cardiac triggering. System functionality was verified against a commercially available
electrocardiography (ECG) system. Monitoring of cardiac activity (detection of the R-R interval in ECG
and the AO-AO interval in SCG) was objectively evaluated by determining the overall probability of correct
detection (ACC), sensitivity (SE), positive predictive value (PPV), and harmonic mean between SE and
PPV, i.e. F1. Imaging quality control using Cardiac Triggering was performed by subjective evaluation of
images by the physicians. The study conducted clearly confirmed the functionality of the system in terms of
continuous cardiac activity monitoring. In all 18 subjects, a mean PPV > 99%was achieved; F1 > 99%; SE >
99%;ACC> 98%; 1.96σ < 3.5 bpm.Also, Cardiac Triggering functionality was confirmed by the physicians
on the basis of analyzing cardiac images using the T1/T2 balanced echo sequences and the T1 flash sequence
measured natively.
INDEX TERMS Seismocardiography-based cardiac triggering, seismocardiography (SCG), siemens prisma
3T, monitor patient vital signs during MRI, cardiac magnetic resonance imaging (CMRI).
I. INTRODUCTION
Cardiac magnetic resonance imaging (CMRI) examination
is important in the diagnosis of ischemic or inflammatory
The associate editor coordinating the review of this article and approving
it for publication was Yue Zhang.
diseases [1]–[3]. This method also enables distinguishing
between reversible and irreversible myocardial changes and
detecting small areas of myocardial fibrosis or inflammation.
Classification of MR signal changes allows monitoring of
the disease process at the tissue level, which is of clinical
relevance for non-invasive disease management. Early and
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FIGURE 1. Typical arrangement of ECG electrodes in an MRI environment;
a) arrangement advantageous for ultra-high magnetic fields and b)
arrangement at field strengths of 1.5 T.
robust detection of scarring or inflammatorymyocardial infil-
tration may allow treatment procedures to be adapted to
prevent or delay disease progression. Another application
of CMRI is to monitor left ventricle function and dysfunc-
tion both in diagnosing local disorders and in diagnosing
global hypofunction, which is an important indicator of many
heart diseases such as coronary artery disease, myocardial
infiltration with inflammatory cells or metabolic products,
various types of cardiomyopathy, changes during diabetes or
hypertension [4], [5].
The synchronization by the methods of triggering and
gating is used in the practice for the insuring of the satis-
factory quality of the heart’s image. These techniques are
essential for the improvement of the image’s temporal and
spatial resolution. The synchronization is based on the cardiac
and respiratory activity monitoring, according to which the
CMRI acquisition is triggered. The goal is to minimize the
negative effect of the heart and thorax motion on the resulting
scan. One of the examples of those artefacts in the image
are so-called ghosts manifesting as the shadows in the MRI
image [6]. The triggering principle is based on the detection
of the most significant change in the electrical signal (e.g.
the R wave in ECG signal) as a reflection of the initiation
of ventricular depolarization and contraction (ventricular sys-
tole). The R wave is referred to as the beginning of the ECG
signal period. For the successful peak detection and consec-
utive synchronization, the task of ECG measurement for the
purpose of MRI triggering is to obtain the most distinct R
wave and a negative or straight Twave, which can be achieved
by changing the electrode arrangement, see Fig. 1 [7]–[10].
The ECG measuring is a means of quick recording of the
cardiac function from which every phase of the cardiac cycle
applicable to MRI triggering can be read. However, when
measured in an MRI device and its magnetic field, many
problems exist, such as artifacts arising from inhomogeneity
of the magnetic field caused by the patients themselves or
foreign materials [11].
For the best possible prevention of artifacts, the skin needs
to be well prepared at the locations of the ECG electrodes in
order to ensure an optimal electrode-to-skin-contact and min-
imal skin impedance which helps with the proper triggering
during CMRI examinations [12], [13]. Hair must be shaved
FIGURE 2. Changes in the ECG signal morphology caused by various
magnetic fields.
immediately prior to the examination and the skin surface
must be scrubbed with mild abrasive soap or gel before the
electrodes are applied, thusmaking the examination relatively
complicated and uncomfortable for the patient [6].
Because of the interaction of the ECG system with
radiofrequency and gradient systems, some security steps are
important for the ECG sensing – ECG, as ameasurement with
the electrically active components, brings a risk of surface
heating of the patient’s skin, or even burns resulting from
high voltage induction in ECG hardware [14], [15]. For the
prevention of the occurrence of the currents in ECG leads due
to the fast switching of the gradient fields, the location of the
leads is designed that loops in the cables are not present and
the wires are as short as possible [6]. The wires are placed out
of resonators for the reducing of the possibility of burns due
to interaction with the RF field [11].
Another important complication in ECG synchronization
is so-called magnetohydrodynamic effect caused by the MR
scanner’smagnetic field, which brings the distortion of the ST
segment of ECG signal. The ECG triggering is not suitable
for the use in the ultra-high magnetic fields, when the effect
of this artifact is increasing – at an intensity higher than 3T,
the recording is significantly distorted in both the spatial and
temporal domains to the extent that the R wave is not unam-
biguously determined because the magnitude of the T wave
equals or exceeds the R wave maxima, see Fig. 2 [16]–[18].
The amplitude of T wave can exceed the R wave for 20 %
of its amplitude, i.e. the amplitude increases on 315 % of the
original T wave magnitude, even with using of the 1.5 T field
intensity [19]. These effects on T and R waves can result in
magnetic scanner startup problems (prolonging the scan time
leading to the economic loss) because R wave is detected
incorrectly, especially at higher magnetic fields (3T and 7T),
see [20], [21].
In this study, pilot clinical verification of a new type
of a seismocardiography based measurement system (SCG)
patented by the authors is presented. This system addresses a
number of the above-mentioned problems of a conventionally
used ECG-based system. Based on the physicians’ experi-
ence, ECG-based systems can be considered as the most
accurate and reliable system used for triggering in clinical
practice. For this reason, the results of this study are verified
using the commercial ECG BRAINVISION – BrainAmp
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TABLE 1. Baseline characteristics of the volunteers.
ExG system by BRAIN Product [22]–[24]. Thus, this study
primarily focuses on measuring cardiac activity.
The original benefit of this article is clinical verification
of functionality of a new cardiac monitoring system, which
is necessary for cardiac triggering. The study was con-
ducted on 18 subjects at a Siemens Prisma 3T MR Scanner
[25], [26] within a multimodal and functional imaging lab-
oratory (CEITEC [27] Research Centre on Life Sciences,
Advanced Materials and Technologies), see [28].
The measurements were conducted on a sample
of 18 healthy persons (volunteers) upon their written consent.
The age group of the volunteers was from 21 to 53 years and
their weight was from 49 to 109 kg. The group of volunteers
consisted of 10 men and 4 women. Table 1 presents the
baseline characteristics of the study volunteers.
To test the cardiac activity monitoring, we used following
types of sequences:
• Standard anatomical sequences
– T1 mprage,
– T2_spc_T2_spc _FLAIR,
• fmri (epi_bold) and diffusion sequences,
• Additional research pulse sequences:
– mp2rage,
– diffusion and functional imaging sequences using
parallel layer excitation, i.e. simultaneous multi-
slice (SMS) sequences.
A wide range of standard diagnostic sequences were used
to test cardiac imaging using triggering with various settings
of planes, phase encoding directions, Cartesian and radial
k-space acquisition:
• Siemens single breath hold methods:
– True FISP (Free Induction Decay Steady-State
Precession),
– True FISP - real time;
– tirm_t2 (Turbo inversion recovery magnitude);
– SPAIR (SPectral Attenuated Inversion Recovery);
– PSIR (Phase sensitive Inversion recovery)
– T2_haste (Half Fourier Single-shot turbo spin echo.
Individual parameters of used sequences are shown
in Table 2. While the cardiac MRI was acquired using stan-
dard pulse sequence and typical parameters used in clinical
practice, both standard (mprage, FLAIR etc.) and state of
the art (multiband fMRI and DWI) pulse sequences were
acquired with physiological data recordings for retrospective
MRI data correction.
II. SYNCHRONIZATION OF CARDIAC AND
RESPIRATORY ACTIVITY IN CMR
CMRI triggering and gating are the techniques necessary to
provide high temporal and spatial resolution of the heart’s
image, which is constantly in motion, in real time [8], [29],
[30]. Synchronization with a cardiac or respiratory cycle is
performed. Besides the most prevalent technique for cardiac
activitymonitoring based on ECG [13], [31], other techniques
are used in the clinical practice – such as vectorcardiograph
(VCG) [32], [33] or a peripheral pulse (PPG, photoplethys-
mography) [34], [35]. In most cases, CMRI examination is
used to trigger the MRI sequence during the relatively resting
heart phase, which is the terminal phase of the diastole or the
systole.
Synchronization respiratory activity is also used to ensure
optimal heart image quality. At present, the most widespread
method of reducing the artefacts caused by breathing is
called breath holdmethod. However, when using this method,
the scanning time decreases according to patient’s ability
to hold the breath, usually to about 20 seconds. One MR
acquisition is acquired throughout a single breath hold, dur-
ing this time, several heart cycles take place [5]. Neverthe-
less, in some patients with certain respirational diseases, this
method cannot be applied. In these cases, real-time respira-
tory activity monitoring can be used for the synchronisation.
The most commonly used probe for MRI respiratory trig-
gering is the pneumatic respiration transducer located on the
patient’s chest [36].
Gating can be divided into two basic principles – prospec-
tive and retrospective. In the prospective gating or trigger-
ing, the MRI sequence is triggered only after the desired
physiological phenomenon is detected (R wave of ECG,
pulse wave peak, AO wave of SCG etc.). In the retrospective
approach, theMR data is recorded continuously and grouped,
after recording, according to the phases of the cardiac
cycle [12], [13].
A. PROSPECTIVE TRIGGERING
In prospective triggering, the MRI acquisition is triggered
by the R wave with a certain delay. Thus, the acquisition is
consistent with the most mechanically resting phase of the
cardiac cycle - the diastasis, which corresponds to the mean
diastolic phase of the ECG signal. Prospective functional
imaging depends on partial k-spatial acquisitions for a series
of images that cover most of the cardiac cycle; the k-space
is eventually filled by averaging the signals from the same
cardiac phase during several heartbeats. This functional file
starts with the R wave [29], [31], [37].
The interval is often set so that the detector deliberately
ignores any high amplitudes to prevent false triggering by an
ECG signal in any other way than by the R wave. However,
this capability is problematic when sensing patients suffer-
ing from arrhythmia with ventricular extrasystole presence.
In patients with premature heartbeats, the earlier R wave
is omitted because the gradient impulses triggered by the
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TABLE 2. Individual parameters of used MRI sequences.
previous R wave are still running. This process extends the
acquisition, thereby extending the time necessary for hold-
ing the breath. Therefore, prospective gating is defenceless
against R-R interval fluctuations not only throughout the
examination, but also within one breath hold. When plan-
ning the acquisition window positioning for prospectively
triggered examination, this cardiac variabilitymust be consid-
ered. So as to capture another Rwave, the acquisition window
position should not be too close to the next R wave. The
acquisition window, which is placed too close, can interfere
with the next R wave and the corresponding R-R interval is
then shorter. Knowing the patient’s cardiac variability during
the breath held is crucial; depending on the patient’s physical
condition, significant changes may occur. Therefore, a breath
hold test is often required before the acquisition itself, when
the appropriate cycle length is measured. During the exam-
ination, the operator must monitor changes in the cardiac
cycle and appropriately adjust the prospectively triggered
images [13].
B. RETROSPECTIVE SYNCHRONIZATION
Retrospective triggering allows continuous acquisition ofMR
data. Both the image and the ECG signal are scanned during
several systoles and used to reconstruct the image by an
appropriate grouping of the cardiac phase information. This
procedure requires dynamic pulse sequences and an acqui-
sition software decision. Retrospective gating uses complex
methods for filtering interference. The main advantage of
retrospective acquisition is the ability to collect data from
all cardiac phases. The retrospective method, like prospective
triggering, may have problems with arrhythmias and low
R wave amplitudes. With heart rate variability or arrhythmia
events, the systole and diastole periods are unevenly altered,
and the retrospective software is unable compensate them
with appropriate data segmentation into which errors are
entered by improper triggering [13], [38]–[40].
C. ARTIFACTS
Artifacts during CMRI measurements may originate in both
the patient and the measurement system. The blood flow
in the heart can induce tension and create hydrodynamic
artifacts. Since blood is an electrically conductive liquid
whose movement produces an electric current added to the
heart signal, a magnetohydrodynamic effect is produced. The
electrical signal thus generated usually affects the Twave. If a
T wave occurs at the time of rapid blood flow from the heart,
the T wave is distorted. When synchronizing using VCG,
which measures the spatial orientation of electrical activity
in three dimensions, this effect can be suppressed because
the cardiac electrical activity and the voltage generated by the
magnetohydrodynamic effect arise in different planes and can
thus be differentiated [9], [13].
Other problems such as abnormal heart conduction or
unrelated physiological processes (e.g., muscle tremors) are
additive to the above-mentioned noise. Optimal image quality
requires an electrode placement that maximizes the R-wave
peak while minimizing these basic artifacts. This can be
achieved by placing the right hand and left foot leads in
the central line of the chest. Extreme changes such as high
amplitude system noise or small electrical currents caused by
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a change in themagnetic field gradient are very worrying, but,
due to the large difference in the frequency at which this noise
and the sensed heart rate signal are found, high frequencies
can be suppressed by filtering [13], [32].
Some scanners have the option of rejecting measurements
at the time of anomalous rhythm and an acceptance window
that allows R-R variability must be specified. This usually
increases the acquisition time and a decision on a shorter scan
time or better image quality must be made and the number of
segments must be increased to reduce the acquisition time.
Extreme deviations of the R-R interval should be overcome
by prospective triggering instead of retrospective. Usually,
a shorter R-R interval should be used for the acquisition
window triggering. Its length must be slightly shorter than
the shortest R-R interval measured in the ECG signal. The
resulting CMRwill represent an incomplete cardiac cycle, but
it will be possible to calculate the ejection fraction.
To reduce distortion caused by the influence of the mag-
netic field, the electrodes and the associated connectors and
cables should be made of non-ferromagnetic material. Con-
tinuous recording of the ECG signal and the triggering events
is essential for early detection of problems. Interference may
falsely trigger the scanner, thereby losing synchronization
with the heart [13].
D. SENSING AT HIGH MR FIELD INTENSITY
In clinical practice, the use of magnet field intensity of 1.5 T
or 3 T is currently widespread. MRI sensing at field intensity
of 7 T promises to increase the signal-to-noise ratio (SNR)
or noise suppression, to increase the contrast between the
myocardium and the blood, to reduce the artifacts in the
image, which leads to better temporal and spatial resolution.
Therefore, monitoring of cardiac cycles is simpler and post-
processing processes that are still time consuming are accel-
erated [41]. In comparison with sensing at 1.5, the contrast
does not only increase in the short-time image of the heart
perpendicular to the blood flow, but also in the long-term
imaging of the heart, evenly with the blood flow. Hence,
fine anatomical structures such as pericardium, mitral and
tricuspid valves and associated papillary muscles are well
identifiable. Due to the increase in SNR, it is possible to
reduce the volume effects that may be useful for visualizing
small, fast-moving structures [4], [42].
Reducing the noise level has a great advantage in MR
angiography, where tiny vessels, such as coronary arteries, are
better visible at an intensity of 7 T than at 1.5 T. In this con-
text, time-resolved 3D flow display along with trace particle
mapping is another interesting and rapidly developing area
of high-intensity CMR. This approach promises new insights
into the temporal and spatial evolution of blood flow in large
vessels and in ventricles. The benefit of this enhancement
would include improving morphological and functional eval-
uation of the normal or pathological cardiovascular system.
In addition, the benefits of SNR in the area of capturing
images at a high field intensity enhance the possibility of
extending the current 4D phase contrast technique to whole
heart acquisitions. The use of high field intensities can also be
used in quantitative CMRI examinations for parametric map-
ping that allows non-invasive tissue assessment. For example,
mapping at 7 T may simplify this operation by easier dis-
tinguishing of healthy tissues from myocardial regions with
reduced perfusion [4].
III. CMRI TRIGGERING METHODS
In stronger magnetic fields, the ECG is significantly distorted
by the artifacts. The VCG method is more resistant to these
negative effects, however, even this method is inaccurate
when ultra-high intensities of MR fields are used. When
using intensities higher than 3 T, there is a problem with the
increasing influence of the magnetohydrodynamic effect on
the signal, making it more difficult to obtain a clear signal of
sufficient quality for performing flawless triggering. While
PPG measurements do not produce significant movement
artifacts, the major disadvantage of PPG measurement is
the delay between the cardiac activity and the output signal
caused by the time needed for the blood pulse wave to spread
from the heart to the sensing location, which is usually found
on the peripheral parts of the body (most commonly the
finger). This delay can be of several hundredmilliseconds and
depends on the patient’s (patho)physiology [43].
As ultra-strong MRI fields become more widespread,
the emphasis is being placed on addressing the rising ECG
sensitivity to electromagnetic field interference and the mag-
netohydrodynamic effect, i.e. the need for better synchro-
nization techniques is increasing [18], [43]. This leads to
the development of the new methods of CMRI triggering,
such as acoustic triggering, ultrasound triggering, or systems
triggering directly fromMR data, have begun to develop [18],
[30], [44].
A. THE ACOUSTIC METHOD
Due to these pitfalls of ECGmeasurement duringMRI acqui-
sition, a stethoscope [18], [45]–[48] that senses a phonocar-
diographic (PCG) signal from which the first heart sound is
determined as a triggering pulse has been designed. Unlike
conventional ECG, heart sound sensing has several advan-
tages – for example, it is easier to prepare the patient (the
location of applying the sensor does not have to be shaved,
the skin is not prepared by any chemical means, the sen-
sor can be placed also over the clothes), the number of
cables and sensors that need to be applied to the patient is
reduced, or the induction of high voltages that may injure the
patient is prevented [18], [49]. The ability of the PCG signal
of both prospective and retrospective triggering, and, later,
its effectiveness in clinical practice for ultra-high magnetic
fields [43], [49], [50], has already been demonstrated on a
field size of up to 3 T [18], [51].
The MRI acoustic control device consists of a sensor
for sensing the PCG signal mounted on the patient’s chest,
wherein the signal conduction is provided by an acoustic
waveguide [43] or optical fibre (in the case of conversion
from acoustic to optical signal) [49], where no PCG device
118612 VOLUME 7, 2019
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
interacts with a static magnetic, gradient, or radio frequency
field. For optimal triggering, the following prerequisites
should be met: 1. maximum latency of 35 ms between the
R waves and the PCG triggering pulses, 2. signal without
electromagnetic field interference, 3. resistance to the mag-
netohydrodynamic effect. The problem of acoustic signal
measurement may be acoustic noise caused by gradient coil
switching, which can be suppressed by measurement with
another sensor and the subsequent signal processing [43].
It has been proved that, when triggered by the PCG sig-
nal, there are no motion artifacts or other visible distur-
bances or the hydrodynamic effect in all MR field mea-
surements (in the range of 0.3 - 7 T). On the other hand,
a significant increase in the T wave amplitude and other
signal distortion are observed from the course of the VCG
curve, where R wave detection demands considerable accu-
racy. Poor registration of the R wave then causes a reduc-
tion in myocardial/blood contrast and image sharpness [18],
[43], [50]. It has been proved that motion artifacts occur
only during ECG signal triggering when MR images are
blurred due to erroneous R wave detection. The ECG heart
rate error rate (especially at high amplitude or rapid sig-
nal rise locations, such as the initial oscillation forming the
R wave) reaches up to 30 % [43], while, for PCG triggering,
an error of less than 1 % is achieved at a field strength
of 7 T [50]. A delay of about 30 ms between the detected
R wave and the first sound that occurs during PCG mea-
surement has no effect on CMR imaging using retrospective
triggering, [18].
B. SELF GATING METHODS
To eliminate the need for extra hardware for CMRI synchro-
nization, so-called self-gating techniques [29], [36], [52] are
used. These techniques use motion information for triggering
directly from MR signals, but at the expense of significant
prolongation of the scanning time. The principle of the CMRI
self-gating method consists in changes or movement of the
volume in the image, where a series of consecutive echoes
exhibit peak changes corresponding to proportional changes
in the total transverse magnetization due to organ movement.
This data is then processed and segmented to generate a
signal replacing ECG, according to which the image is then
reconstructed at each cardiac cycle. Most of these methods
have already been successfully used for retrospective CMR
triggering, which is not as sensitive to heart rate changes
(as in prospective triggering) and provides image throughout
the cardiac cycle, which is particularly important for the
determination of diseased systolic or diastolic processes [29].
However, these techniques lag behind in the case of very high
heart rate and some heart diseases, wheremyocardial contrac-
tion and relaxation are verymild throughout the cardiac cycle.
Also, they are unsuitable for use in prospective triggering,
which requires precise determination of the start-up delay,
so that an acquisition window could be placed in the target
phase of the cardiac cycle [18], [29], [39].
C. THE ULTRASOUND METHOD
An interesting alternative to standard ECG triggering is the
use of an ultrasonic probe in Doppler mode. Ultrasonic
recording allows RR intervals to be measured similarly as
ECG, and, as for image quality, the method equals ECG and
PPG. So far, this method of triggering has been verified on
CMRI at an intensity of up to 3 T [8], [30], [53], [54], but it
also promises usability at higher field intensities, due to the
low susceptibility of the ultrasound signal to being influenced
by the magnetic field, unlike the ECG signal, which is very
often significantly distorted by the magnetohydrodynamic
effect [55], [56].
D. THE OPTICAL METHOD
Some studies investigate the possibility of sensing cardiac
activity by optical fibre, but only when used in rodents [46].
The sensor is orally introduced into the rat’s oesophagus [46]
or is placed on the chest to sense movement [57]. The advan-
tage is the resistance of the optical fibre to the interference
caused by the magnetic field; there are no movement artifacts
in the image [58]–[61].
IV. DESCRIPTION OF THE MEASURING AND
TRIGGERING SYSTEM HW AND SW
The SCG is a method for studying the mechanical vibra-
tions which are produced by cardiovascular activity. Common
sensors used for SCG monitoring are accelerometers. They
can measure acceleration in three axis and give complete
information about the heart movement.
The SCG, as monitoring technique, is receiving increasing
attention. In special cases, such as monitoring CA during
MRI, the accelerometer cannot be standardly used. The mea-
sured signal would be influenced by changing magnetic field
and inducted currents.
In this paper, we proposed a SCG monitoring method that
relies on non-magnetic materials which do not affect MRI
examination. The ECG monitoring is standard monitoring
technique for triggering of MRI by AO. To successfully
develop the adequate system, we must firstly understand rela-
tions of ECG and SCG signal measured by proposed setup.
The presented equipment was different from the standard
SCG monitoring tools and was therefore studied in detail.
One of the most significant changes in standardized SCG
measurement is that our system measures the acceleration
in one vector perpendicular to the location of the sensor on
the patient’s chest. Sensing of the patient’s SCG signal is
conducted by means of a plastic funnel (produced by the
3D printing method), which is fixed to the patient’s chest by
means of an elastic textile belt in the area where the heart is
located. A PVC acoustic tube is attached to the end of the
funnel, and this tube is brought into the control room, where
it is subsequently connected to a measuring microphone.
In this way, a closed acoustic environment is created which
is highly resistant to external vibrations and sounds. The
source of the signal is the movement of the patient’s skin
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FIGURE 3. The schematic diagram of the measuring and triggering system; a) Plastic funnel fixed by elastic belt at patient chest,
b) Acoustic tube for transmitting modulated pressure by the patient’s heart, c) Measuring microphone, d) Analog input,
computing unit and digital output, e) Triggering signal for magnetic resonance imagining.
below the sensor. The patient’s skin forms a membrane that
moves due to the expulsion of blood from the heart to the
aorta and the pulmonary veins. This movement may include
superimposed interference caused by uneven skinmovements
due to heterogeneous chest structure. As a result, the shape
of the SCG curve is directly dependent on the location of
the sensor on the chest. The patient’s skin movement vibrates
the particles of the acoustically closed environment inside the
funnel and the resulting pressure oscillations spread through
the tube to the measuring microphone which converts them
into a voltage signal. The microphone output is brought into
the input of the analogue-to-digital converter (ADC), where
it is digitized and then processed and analysed in the control
unit. Based on the signal analysis performed, the control unit
generates a triggering signal for prospective and retrospective
gating of magnetic resonance. The schematic diagram of the
described system is shown in the following Fig 3. The most
important advantage of this system is its resistance to elec-
tromagnetic and acoustic interference in magnetic resonance,
and its ability to measure during imaging.
The basic advantage of this configuration of the measuring
device is the fact that the SCG signal transmitted is not largely
modified when passing through the acoustic conduction.
Measurements that were conducted using different acoustic
conduction lengths (0 to 30 m) revealed that only minor
nuances in the area of the frequencies characteristic of the
SCG signal (i.e. 0 to 30 Hz) occur. The difference observed
in the spectrum of the signal measured at the beginning and at
the end of the acoustic conduction is up to ± 5 dB (it differs
by signal deviation). An important parameter is the difference
seen in the temporal domain of the signal in the form of signal
delay. This is due to the limited maximum velocity of the
excitation transfer depending on the media material inside
the acoustic conduction, i.e. air. The distance-velocity lag
is variable and directly related to the length of the acoustic
conduction and the propagation of the pressure wave outside
it. In this particular case, the acoustic conduction had a length
of 11 m; according to the measurement, the distance-velocity
lag of the signal measured was about 37.5 ms (i.e. the propa-
gation rate is 290 ms−1). Knowing the value of the distance-
velocity lag is necessary for the correct setting of the time
delay from the R-oscillation detected. When the SCG signal
delay time correction is performed properly, the operator can
access imaging when tuning the time delay as well as when
using the ECG signal. Magnetic resonance measurements
also revealed that the interference signals produced during
the scanning sequences (vibration of the magnetic resonance
structure and its acoustic manifestations) have a typical dis-
tance of about 20 dB from the useful signal.
The measuring and triggering systems were completely
designed on the basis of virtual instrumentation. cRIO-
9073 platform [62] made by National Instruments was used
as the control unit [63], [64]. The cRIO platform was selected
as it consists of a combination of a gate array (FPGA) and a
controller with VxWorks real-time operating system (RTOS).
This interconnection enables fast analysis of the signal mea-
sured and very accurate generation of the triggering sig-
nal over time with a resolution ranging from microseconds
to hundreds of nanoseconds. The Human Machine Inter-
face (HMI) is not part of the selected cRIO model, so a
PC, which is connected to the cRIO via an Ethernet inter-
face, is also included in the control unit. The SCG signal
is sensed using a GRAS 40PP microphone [65]–[67] with
a frequency range from 10 Hz to 20 kHz and a sensitivity
of 50 mW/Pa. The cRIO used has four slots for connecting
input/output modules. For microphone signal measurement,
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FIGURE 4. A detailed description of the control unit with a detailed
description of the gate array logic.
the cRIO-9250 module [68] was selected, which features
2 simultaneous ADC channels with a 24-bit resolution,
a ± 5 V input range, and a sampling rate of up to 102.4 kS/s.
The module is used for very accurate vibration measurement
using microphones and accelerometers. The triggering signal
is generated using the second cRIO-9472 module [69], which
consists of 8 digital outputs, 6 V - 30 V compatible, capable
of delivering a current of up to 0.75 A per output channel.
A detailed diagram of the entire control unit with a detailed
analysis of the lowest gate array layer is shown in the fol-
lowing Fig. 4. The measuring and triggering system func-
tion is controlled by a three-layer SW application created
in the LabVIEW [70]–[72] development environment and
its expansion modules (Real-Time and FPGA). The lowest
and most important SW layer is implemented for FPGA.
Its task is to read values from ADC, process and analyze
the digitized signal in real-time and, subsequently, gener-
ate a digital triggering signal of a user-defined width and
an adjustable delay. The processing involves digital sig-
nal filtering with a fourth-order low-pass infinite impulse
response (IIR) filter with Butterworth approximation and a
cut-off frequency of 40Hz.We used IIR filter implementation
because it generally requires less FPGA resources (especially
memory elements) than finite impulse response (FIR) filter
implementation. Additionally, the FIR filter may cause longer
time delay, which is highly undesirable. We tested both FIR
and IIR filters in LabVIEW development environment before
we implemented it using the FPGA module. Both filters
performed nearly the same. The nonlinearity of the IIR filter
phase frequency response had no effect on the SCG signal
morphology. For selected sampling frequency, the FIR filter
implementation would require around 400 taps to achieve the
same amplitude frequency response as IIR filter. That would
cause slightly longer (a few milliseconds) time delay of the
processed SCG signal leading to a delay in generating the
triggering signal. The filtered signal is analyzed by a simple
peak detector implemented directly into the FPGA logic. The
user can configure the detector by defining the refractory time
(time after the detected peak when the system does not expect
a new peak to occur) and the signal level threshold coefficient.
The implemented gate array logic also allows transmitting
the measured signal waveform, the trigger generated, and the
information on the peak detected to the RTOSmicrocontroller
via the DMA FIFO channel. The microcontroller then for-
wards the signals to the PC, where they are displayed to the
user/operator, via the Ethernet interface.
The middle layer of the SW application is implemented for
the RTOS controller and serves as a bridge for data transfer
between the FPGA and the user PC. Two TCP servers are
implemented here, wherein the first server receives configu-
ration commands from the user PC, recalculates the values,
and then writes them to the registers shared with the gate
array. The second server reads the data stream from the DMA
FIFO gate array and sends it to the connected user PC. The
highest SW layer is implemented on the PC and includes two
TCP clients that connect to servers running on the RTOS and
a user interface allowing the configuration of the cRIO system
and displaying the waveform of the signal measured, the peak
detected and trigger generated. The below-listed Fig. 5 shows
FIGURE 5. The waveform measured and the signals generated by the gate array logic (SCG signal with detected
peaks generated trigger).
VOLUME 7, 2019 118615
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
FIGURE 6. The illustration of the sensor placement. a) Measurement sites
of mechano-acoustic signals with respect to the heart anatomy: 1. Aortic,
2. Pulmonary, 3. Tricuspid, 4. Bicuspid; b) Recommended areas for the
placement of the sensors for the heart sounds measurement (red) and
the seismocardiography (blue).
FIGURE 7. Placement of the sensor tested on the patient’s body.
a graph containing all the signals measured and generated by
the gate array logic.
Fig. 6 shows the illustration of probe positioning with
respect to the areas used for heart sounds auscultation. The
optimal location of the seismocardiograph sensor [73]–[76]
was selected as an area with audible heart sounds and a
surface ensuring the hermetic sealing of the measurement
system.
Fig. 7 shows the placement of the SCG sensor tested on
the patient’s body. The sensor is fixed by means of an elastic
belt, where you can the acoustic conduction emerging from
the belt. A commercial ECG system can also be seen in the
figure.
V. EXPERIMENTS
For triggering and physiological signals acquisition with
Siemens Physiological Measurement Unit (PMU) using
sensor – ECG electrodes, respiratory cushion and pulse sen-
sor - directly at the patient via the PERU (ECG, respi-
ration) and PPU (pulse). [MR System | Operator Manual
Print No. M7-04001.621.04.01.24] The Siemens device
physiological data export is complicated and, moreover,
the sampling rate is relatively low, so BRAINVISION -
BrainAmp ExG system [77] made by BRAIN Product is
used for recording the signals for the purpose of retrospec-
tive correction and removal of the physiological effects from
FIGURE 8. A typical resting seismocardiogram (SCG) and matching
electrocardiogram (ECG).
the MR data. The curves presented below come from the
BRAINVISION system. For the purposes of this article, all
three devices, PMU, BrainAmp ExG and SCG, were usually
used simultaneously.
Standard anatomical (T1mprage, T2_spc_T2_spc_FLAIR),
fmri (epi_bold) and diffusion sequences, as well as state-of-
the-art research pulse sequences (mp2rage, and diffusion and
functional imaging sequences using parallel layer excitation -
SMS or also calledmultiband), were used for testing SCG and
respiratory. These sequences are then the most demanding in
terms of high-frequency interference, magnetic and acoustic
interference and vibration caused by the gradient system
when the noise of these methods can exceed 120dB.
A. ECG VS. SCG WAVEFORMS AT SELECTED SEQUENCES
To demonstrate the functionality of the SCG system tested
from the point of view of vital signs monitoring during the
selected sequences, short time domain previews, a) ECG
signal and b) SCG signal, are interpreted below. The authors
divided these previews into three groups:
1) both the ECG and SCG commercial systems work well,
see Fig. 10 and Fig. 11;
2) the SCG system tested works well, the commercial
ECG system introduces errors (undetected or falsely
detected R) into the measurement, see Fig. 12, Fig. 13
and Fig. 14;
3) the SCG system tested works well, the commercial
ECG system does not work at all, see Fig. 15 and
Fig. 16.
The criterion of functionality is defined by the heart rate in
the case of the ECG signal, namely, it is based on the detection
of the R-R interval and, in the case of the SCG signal, it is
based on the detection of the AO-AO interval, see Fig. 8.
Fig. 9 further shows the delay (approximately 45 - 120 ms)
of AO after R; this is caused by biological processes in the
human body, but also by the measuring system itself (about
50 ms), where the signal propagation time of the transmission
medium must be taken into consideration (approx. 3.4 ms
per meter) as well as the delay caused by signal processing
(filtration) (approximately 15 ms).
Fig. 10 shows a preview of a) ECG and b) SCG before
running the sequence (resting state) [78]–[80]. Obviously,
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FIGURE 9. The delay (∼170 ms) between significant points (R-AO)
detected in ECG and SCG on measured subject.
FIGURE 10. A waveform of a) ECG and b) SCG before running the
sequences (Resting state).
FIGURE 11. A waveform of a) ECG and b) SCG during the sequence
(T2 weighted with fat suppression using the SPAIRE method).
the signals measured are of good quality, without artifacts
and interference, so there is no problem in detecting the
R-R and AO-AO intervals the detection of which is abso-
lutely necessary for cardiac triggering based on the cardiac
activity.
Fig. 11 shows the waveforms of a) ECG and b) SCG with
the sequence already running (T2 weighted with fat suppres-
sion using the SPAIRE method). Obviously, the sequence
had no effect on the SCG signal, whereas the ECG signal is
greatly degraded by switching of the high frequency pulses
during the running sequence. However, the ECG signal is still
useful for determining R-R intervals.
When looking at Fig. 12, Fig. 13, it is obvious that the
ECG system will cause a significant error in cardiac trig-
gering because we are unable to accurately detect the R-R
interval. The TRUE FISP sequence used to make a kinetic
study, or T1 weighted with PSIR saturated myocardial signal
suppression. There is no problem with the detection of the
AO-AO interval in the SCG system, i.e. cardiac triggering
is possible. In Fig. 12 and Fig. 13, the ECG system may
detects false R intervals (e.g., between the 4th and 5th second,
Fig. 12a), resulting in inaccurate sequence triggering, which
may cause artifacts in the image.
Fig. 14 shows that, with the ECG signal, we are not
able to correctly detect the R-R interval (there is a large
FIGURE 12. A waveform of a) ECG and b) SCG during the sequence
(TRUE FISP sequence used).
FIGURE 13. A waveform of a) ECG and b) SCG during the sequence
(T1 weighted with PSIR saturated myocardial signal suppression).
FIGURE 14. A waveform of a) ECG and b) SCG during the fMRI BOLD
sequence.
number of undetected and falsely detected R oscillations),
whereas, with the SCG signal, there is no problem with the
AO-AO interval detection. The sequence used was fMRI
BOLD.
When looking at Fig. 15, Fig. 16, it is obvious that, with
the ECG system, we are not able to detect R oscillations at
all, since the signal is completely jammed by high-frequency
interference, which was, due to aliasing, mirrored into the
frequency domain of the useful ECG signal and cannot be fil-
tered. The SCG system tested works smoothly again. Fig. 14
is a sequence of diffusion weighted echo using epitechnics
which is characterized by a high potential for triggering
involuntary nerve or muscle spasms. Fig. 15 is a sequence
of 3D T2 weighted TSE ECHO - SPACE.
B. INFLUENCE OF SUBJECT MOTIONS IN POSTURAL
POSITION ON SCG SIGNAL
As part of our research we did an assessment of the influence
of subject motions in postural position on quality of acquired
SCG signal. For this experiment we selected one male subject
and measured the SCG signal while the subject was per-
forming motions typical for postural position, which subject
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FIGURE 15. A waveform of a) ECG and b) SCG during the sequence of the
diffusion weighted echo using epitechnics.
FIGURE 16. A waveform of a) ECG and b) SCG during the sequence of the
3D T2 weighted TSE ECHO - SPACE.
FIGURE 17. Example of: a) measured SCG signal when subject lies still
and b) its corresponding amplitude frequency characteristics.
occupies during MRI exam procedure. Performed motions
were:
• head motions ( slow turning to sides and slight leaning
forward and backward),
• restless leg motions (twitching, slight turning and bend-
ing),
• speaking,
• heavy and deep breathing,
• torso wriggling (slight motions to sides),
• torso twitching (trying to get thorax and head up for
repositioning).
Acquired SCG signal was only processed by the lowpass
filter with configuration described in the previous section.
In case of head motions, leg motions, slight torso wrig-
gling and heavy or deep breathing, there were only minor
distortions of the SCG signal. These motions only had a
slight impact on the performance of peak detection algorithm.
Speaking and torso twitching was causing considerable dis-
tortions of the signal, that made the correct detection of AO
peak impossible. Frequency components of analyzed motion
artefacts occupy the same band as components of SCG sig-
nal (1 Hz - 40 Hz). This makes filtration of distorted SCG
signal using conventional linear IIR or FIR filters impossible
so advanced signal processing methods would have to be
employed. Fig. 17 to 20 display samples of SCG signals
FIGURE 18. Example of: a) measured SCG signal while subject was
speaking and b) its corresponding amplitude frequency characteristics.
FIGURE 19. Example of: a) measured SCG signal while subject performed
torso twitching motions and b) its corresponding amplitude frequency
characteristics.
FIGURE 20. Example of: a) measured SCG signal while subject performed
torso wriggling motions and b) its corresponding amplitude frequency
characteristics.
in time and frequency domain acquired when patient lays
still and when performing selected motions. To illustrate the
influence of motion artefacts in comparison with reference
signal (patient lies still, Fig. 17), we deliberately used fixed
ranges for Y-axis in these figures. In conclusion, motion
artefacts can cause problems with peak detection and thus
could devaluate the results of MRI exam due to incorrect
triggering. However these motion artifacts would propagate
into acquired MR exam images even if the triggering was
accurate and devaluate theMRI exam results anyway. For this
reason the patient is required to lie as still as possible during
the MRI exam which, in case of cardiac monitoring lasts only
about 10 to 15 seconds.
It is clear that themorphology of the individual SCG curves
changes, see Fig. 11b) to Fig. 16b). This is due to the different
locations (more in the following paragraph), the size of the
contact area between the patient’s body and the sensor, but
also the pressure of the measuring sensor, and, moreover,
the waveforms from different subjects (men vs. women),
various BMIs, etc.
Two volunteers, a man and a woman, participated in a
sensor placement experiment. According to the measurement
(Fig. 21), the shape of the SCG signal is directly dependent
on the sensor location (Fig. 6). Although the signal does not
118618 VOLUME 7, 2019
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
FIGURE 21. Representation of averaged and normalized SCG signal from
a) Male and b) Female patient.
match the typical SCG curve, it always contains a significant
peak that could be used to detect the heart cycle. To map
this phenomenon, an additional study outside the MRI would
have to be performed to map the characteristic curve shape
depending on the sensor position. Furthermore, this informa-
tion could be incorporated into the heart cycle detector to
increase its accuracy.
C. RESULTS
In our experiments, we considered the ECG as the ’’gold
standard’’ since the ECG-based systems are the most com-
monly used in clinical practice. According to the professional
public, they reach the highest accuracy from the perspective
of cardiac triggering. However, this argument is not sufficient
to call the ECG system ’’gold standard’’. All ECG signals,
which were used for the evaluation, were classified semi-
automatically in the R-R intervals determination. This way,
we gained the total number and time position of the heart
beats in individual subjects (e.g. 821 beats in subject_1, etc.).
Also, we took into account the time delay between ECG
and SCG signal during analysis so that the distortion could
not occur. Thus, we could establish our annotations for the
verification of the SCG system.
For the relevant verification, only the sections where the
reference ECG was recorded for us in good quality (i.e.,
the R-oscillations could be demonstrably detected) were
deliberately selected, see Fig. 8. The data were obtained from
18 different patients (10 men and 8 women aged 20 to 45,
all healthy, all with ethics committee approval). It should
be noted that the SCG system tested is completely immune
to electromagnetic and acoustic interference during all the
sequences tested. Thus, it can be said that it achieves better
results than the ECG reference, which is strongly influenced
by the nature of the interference during the running sequence.
Fig. 22 includes a comparison of ECG and SCG signals
along with the detection of significant points in these curves.
A significant point (AO) in the SCG signal monitored should
be detected within a range of ± 50 ms from the R wave
detected in the ECG signal. Fig. 22a) shows a section where
accurate detection of a significant SCG signal point was
achieved in accordancewith the reference ECG signal. There-
fore, these points were labelled as true positive (TP). On the
contrary, Fig. 22b) shows a signal section where there is an
error in detecting a significant SCG signal point. If a point
was detected outside the defined interval, it was labelled false
positive (FP). On the other hand, false negative (FN) detection
occurred when, in the range of ± 50 ms from the R wave
detected, AO wave detection did not occur in the SCG signal.
These errors appeared in sections where MO wave reaches a
magnitude comparable to AO wave, so it was detected as an
FP peak. Consequent AO wave was therefore not detected,
as the detector refractory time, when the system is inactive,
was still running because it does not expect a new peak to
occur.
It is also important to note that the points shown in Fig. 22
are located in some places outside the peak of the ECG
signal peak. This is due to the fact that the DC component
was removed during the signal analysis, and, subsequently,
detection in this signal was conducted. Thus, in the resulting
signal, the detected points manifest themselves in the correct
period of time, but at a different voltage level.
For all 18 patients a detection of significant points in
reference ECG and tested SCG signals (samples shown
in Fig. 23 to 30) was performed and based on the analysis
described in Fig. 22, their binary classification (a decision
whether the significant point falls into the category of TP,
FP or FN) was conducted. Results of binary classification
were then used to determine 4 performance parameters of
peak detection in SCG signal. First parameter is sensitivity
(SE, true positive rate or recall, see equation (1)), it measures
the percentage of correctly identified peaks. Next Positive
predictive value (PPV or precision, see equation (2)) mea-
sures percentage of identified peaks that are truly correctly
identified as positive. Further Accuracy (ACC or statistical
bias, see equation (3)) defines ration of correct identification
to all identifications made. Finally F1 score (see equation (4))
considers both SE and PPV as a harmonic mean of these two
parameters. In medical tests, results above 95 %, mean high
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In the medical field, the Bland-Altman (mean-difference)
plot is used to compare the results of two independent mea-
surements of the same variable. The principle of this method
is based on determination of the differences between individ-
ual results of two measurements, see equation (5), where X
and Y are vectors of results of the individual measurements.
Difference vector is then used to determine mean valueµ and
1.96 multiple of standard deviation 1.96σ of all differences.
Next vector of mean values of individual results of the two
measurements, see equation (6), is determined. Finally the
Bland-Altman plot is constructed using the vector of mean
values (X-axis) and vector of differences (Y-axis). Also a
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FIGURE 22. Evaluation of detection of significant points in ECG (Red) and SCG (Green) signals: A) successful detection section
- significant points were detected in the SCG signal within an interval of ± 50 ms (blue) from the detected R wave in the ECG
signal, thus labelled as true positive (TP); B) an example of a false positive (FP) and false negative (FN) detection section,
the points were detected outside a given interval or were not detected in the given interval.
bold horizontal reference line is drawn at µ, this line rep-
resents mean difference between all measurements and if it
significantly differs from 0 then it indicates fixed bias in
the measurement. Additional two horizontal lines, known as
limits of agreement, are drawn at µ ± 1.96σ , they represent
range of agreement, within which the differences between the
two measurements are expected to fall with 95 % probability
(assuming the data comes from normal distribution) [58],
[81], [82].
−→
D = (D1,D2, . . . ,Dn), where Di = Xi − Yi. (5)
−→




The below-listed figures (Fig. 23 to 30) show a) a preview
of the reference ECG signal section during the examination,
b) a preview of the SCG signal section tested. The last sub-
figure c) represents the Blant-Altman graph, which statis-
tically assesses the determination of vital signs during the
examination, where the length of the determined R-R interval
was used as a reference and as the evaluated length of the
determined AO-AO interval. These waveforms are displayed
for selected subjects tested; the length of the examinations
during each sequence, but also during the resting state, was
different.
Table 3 summarizes the achieved results of Bland-Altman
analysis (columns µ and 1.96σ ) and binary classification in
all 18 subjects with those displayed in Fig. 23 to 30 being
highlighted in bright green and bright red colors. Bland-
Altman analysis indicates a difference bias for subject 1, 2,
3 and 5 with subject 1 having the worst result of -0.63 bpm.
Also limits of agreements for these subject are significant,
ranging from 6 bpm to 10 bpm. This results correspond with
results of binary classification, which shows higher number
of false positives (FP) and false negatives (FN) for men-
tioned subjects and also ACC and F1 parameters are lower
in comparison with other subjects. These worse results are
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TABLE 3. Summarization of the results achieved on all subjects tested.
FIGURE 23. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_1.
FIGURE 24. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and c)
Bland-Altman plot for subject_2.
mainly caused by presence of outliers in determined heart
rates as shown in Fig. 23, 24, 25 and 27. Outliers are results
FIGURE 25. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_3.
FIGURE 26. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_4.
of either movement artefact or imperfect sensor position-
ing. Both issues could be solved by employment of more
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FIGURE 27. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_5.
FIGURE 28. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_6.
FIGURE 29. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_7.
advanced signal preprocessing of SCG signal and by increas-
ing robustness of peak detection algorithm, which could be
subject of further system improvements. Sensor reposition-
ing is not an option, because it would significantly prolong
patient preparation phase, which is highly undesirable in
FIGURE 30. Statistical analysis. a) ECG (R-R), b) SCG (AO-AO) and
c) Bland-Altman plot for subject_10.
clinical practice. Best results were achieved for subjects 4,
6, 7 and 10 (Fig. 26, 28, 29 and 30) with difference bias to
be almost zero (-0.02 for subject 4) and limits of agreement
in range from 0.59 bpm and 1.1 bpm. Binary classification
results shows both ACC and F1 parameters to be over 99.7 %,
which indicates almost perfect match. Results from remain-
ing 10 patients have almost zero difference bias, considerably
low limits of agreements in range from 1.37 bpm to 3.55 bpm
and their ACC and F1 parameters lies in range of 98.9 %
to 99.7 %. Last row of the Table 3 shows results of binary
classification of detected peaks obtained from all measured
subjects altogether. In total, 15 719 heart beats (peaks) were
detected, with 14 956 correctly identified as true positive
peaks, 116 incorrectly detected false positive peaks, and
106 missed peaks (false negative). For all subjects the total
accuracy reached 98.53% and F1 score reached 99.26%. The
results prove that the SCG signal can be used as substitute for
ECG signal during magnetic resonance exam with reliability
of correct heart beat detection reaching up to 99 %.
In the case of this work, ECG is used as the reference
method, and SCG is used as the test method. The results of
the ACC, SE, PPV and F1 parameters are marked as accurate
if they exceed 95 % [58], [81].
D. CARDIAC TRIGG ECG VS. SCG
A wide range of standard diagnostic sequences was used
for cardiac imaging using triggering. Siemens single breath
hold methods True FISP (Free Induction Decay Steady-State
Precession), True FISP – real time; tirm_t2 (Turbo inversion
recovery magnitude); SPAIR (SPectral Attenuated Inversion
Recovery); PSIR (Phase sensitive Inversion recovery) and
T2_haste (Half Fourier Single-shot turbo spin echo) with var-
ious settings of planes, phase encoding directions, cartesian
and radial k-space acquisition, using all previouslymentioned
methods of cardiac triggering SCG, EKG, pulse oximeter;
retro and prospective.
To demonstrate the functionality of cardiac triggering,
the most common sequences for cardiac imaging in MR were
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FIGURE 31. Resulting cardiac MRI of a 4-chamber view obtained using ECG (left) and SCG (right) triggering system.
used: the kinetic method - Tru FISP, and the method for
detecting myocardium saturation - T1 flash, see Fig. 31 and
Fig. 32 below, where ECG triggering was used on the left side
and triggering using the SCG system tested on the right side.
Fig. 31 shows a scan of 4-chamber (4-cavity) T1/T2 plane
of sequences of the balanced echo - Tru FISP by Siemens,
Erlangen, Germany. Both images display good tissue
contrast, particularly at the site of flowing blood and
myocardium, without distortions at the transition site. In a
3-T device environment, the study of cardiac sections is very
sensitive to movement and transition artifacts - flowing blood
- left ventricle muscle; flowing blood - papillary muscles,
which both ways of triggering cope well with, but still, from
a medical point of view, in the SCG sequence, the image
appears sharper (interventricular septum), with a higher con-
trast between light blood and dark muscle (especially the
heart septum and papillary muscles), which may be a good
guide especially for segmentation of cardiac sections.
Fig. 32 shows a study on a volunteer, natively, con-
trast medium not administered. T1 flash sequence measured
natively - is intended to evaluate late enhancement. In the
images demonstrated, there is a 2CH (2-cavity) image, where
the left ventricular contour is well detectable in both trig-
gering methods; sequences with both triggering methods are
medically fit for use.
Based on the subjective evaluation of the images, Fig. 31
and Fig. 32, shown above performed by physicians, the results
of the effectiveness of cardiac activity monitoring were also
TABLE 4. Results of the image quality evaluation based on BRISQUE
method.
confirmed by cardiac triggering. It can be stated that cardiac
activity monitoring is at least fully comparable with the sys-
tems used in clinical practice, which is unequivocally demon-
strated by the comparison of the above-mentioned images.
In addition to the subjective view of radiologists, the qual-
ity assessment of images from MRI was also carried out
by software quality analysis using the Blind/Referenceless
Image Spatial Quality Evaluator (BRISQUE) [83], [84]. The
output of this method is a numerical quality score, which
takes values from 0 (best) to 100 (worst). Quality analysis
was performed for Fig. 33 and 34. The Quality Score is shown
in Table 4. The results of image quality analysis show that in
all cases during the cardiac triggering were achieved by the
our system equivalent or better images quality.
Results presented in Table 4 show that the SCG method
is equivalent to the ECG-based triggering. The quality of the
scans is comparable regarding the BRISQUE method.
VI. DISCUSSION
The benefit of the system tested is the higher reliability and
stability of the signal measured, without limiting the depth of
the patient’s inspiration (deepened inspiration, especially in
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FIGURE 32. Resulting cardiac MRI in sagittal plane obtained using ECG (left) and SCG (right) triggering system.
FIGURE 33. Parts selected for the objective image quality evaluation
using BRISQUE (4-chamber; T1/T2 plane of sequences of the balanced
echo). Left: Scan triggered by means of ECG (upper image: Whole scan;
lower image: Cropped scan); Right: Scan triggered by means of SCG
(upper image: Whole scan; lower image: Cropped scan).
time-consuming examinations requiring the patient to con-
centrate on breathing). Furthermore, it should be noted that
the system tested is fully compatible with various MRI man-
ufacturers. The test system appears to be very convenient
for examinations where the emphasis is placed on continu-
ous cardiac activity monitoring regardless of the sequence
selected. For example, it is beneficial for patients with
malignant arrhythmias where continuous monitoring is an
essential part of patient care.
Another advantage of the system tested from the perspec-
tive of the patient, but also of the operating staff, is easier
handling with the sensor itself when placing it on the body,
see Fig. 7. This leads to faster preparation of the patient for
examination, as there is no need to prepare the skin (shaving,
degreasing, etc.) to attach themeasuring electrodes. This pilot
study has shown that the system tested is not dependent on
the depth of inspiration. This seems to be very convenient
for patients who have a problem to cooperate during the
examination (small children, seniors, etc.). In systems that
are currently used in clinical practice, measurements often
have to be repeated. This problem is completely eliminated
with the system tested. It can be assumed that thanks to
the aforementioned benefits, the system tested can reduce
the examination time and streamline the workflow in the
workplace.
The disadvantage of the system devised is its susceptibil-
ity to the patient’s movement artifacts. If the patient moves
during the examination, false positive (FP) values and false
negative (FN) values may occur.
The subject of further research will be usability testing
for cardiac MR, neurofunctional brain imaging - diffusion
tensor imaging, functional MRI, or a fluid flow detection
study. Furthermore, analysis and verification of functionality
in very high fields (7 T - AKH Vienna) will be conducted.
Next, the collective of authors intends to focus on utilization
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FIGURE 34. Parts selected for the objective image quality evaluation
using BRISQUE (T1 flash sequence measured natively). Left: Scan
triggered by means of ECG (upper image: Whole scan; lower image:
Cropped scan); Right: Scan triggered by means of SCG (upper image:
Whole scan; lower image: Cropped scan).
TABLE 5. Total price of the proof of concept measuring system.
TABLE 6. Estimated price of a series-produced measuring system.
of respiratory monitoring with implementation in cardioMRI
sequences.
To verify the principle of the presented device, the NI
virtual instrumentation tools were used (Table 5). This equip-
ment was chosen, because it allowed rapid prototyping of
TABLE 7. The comparison of monitoring systems.
the proposed triggering system. The initial tests included the
successful use of low-cost components described in Table 6.
Table 7 shows the comparison of the tested systems with the
commercially available systems for synchronous measure-
ment utilized in the MRI of the research center CEITEC,
Brno.
VII. CONCLUSION
This pilot clinical study unambiguously confirmed the func-
tionality of the SCG-based system tested in terms of contin-
uous cardiac activity monitoring and the subsequent cardiac
triggering. In all 18 subjects tested, cardiac activity was con-
tinuously monitored throughout the examination, regardless
of the type of sequence being run. It can be stated that the
SCG system tested is completely immune to all sequences
tested within Siemens Prisma 3T. System functionality was
verified against a commercially available ECG-based sys-
tem (BRAINVISION - BrainAmp ExG system by BRAIN
Product). Unfortunately, this reference system did not work
reliably for a number of sequences, e.g. during a sequence
of diffusion weighted echo using epitechnics, or during a
sequence of 3D T2 weighted TSE ECHO - SPACE, see Chap-
ter 5.1. For this reason, only the sections where R oscillation
could be correctly detected were manually selected for the
statistical analysis, so that the analysis was not distorted,
see Chapter 5.2. In all 18 subjects, a mean PPV > 99 %
was achieved; F1 > 99 %; SE > 99 %; ACC > 98 %;
1.96σ ;< 3.5 bpm, see Table 2. Also, Cardiac Triggering
functionality was confirmed by the physicians on the basis
of analyzing cardiac images using the T1/T2 balanced echo




Project Title:MR imaging sequences and protocols optimiza-
tion aiming to application of new coil and pulse sequences
Proposal: 0319/2018
Investigator: Ing. Lubomir Vojtisek, Ph.D.
Organisational Unit: CEITEC
The Research Ethics Committee of Masaryk University
has reviewed the application to conduct the research project
as specified above and on 8 June 2018 the Committel
has approved this project to be conducted. The Committee
expects to be informed about any revision in the research pro-
VOLUME 7, 2019 118625
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
tocols and/or informed consent form and ask to be provided
a copy of the final report.
REFERENCES
[1] J. Rieber, A. Huber, I. Erhard, S. Mueller, M. Schweyer, A. Koenig,
T. M. Schiele, K. Theisen, U. Siebert, S. O. Schoenberg, M. Reiser, and
V. Klauss, ‘‘Cardiac magnetic resonance perfusion imaging for the func-
tional assessment of coronary artery disease: A comparison with coronary
angiography and fractional flow reserve,’’ Eur. Heart J., vol. 27, no. 12,
pp. 1465–1471, Jun. 2006. doi: 10.1093/eurheartj/ehl039.
[2] H. P. Kühl, M. Schreckenberg, D. Rulands, M. Katoh, W. Schäfer,
G. Schummers, A. Bücker, P. Hanrath, and A. Franke, ‘‘High-resolution
transthoracic real-time three-dimensional echocardiography: Quantitation
of cardiac volumes and function using semi-automatic border detection
and comparison with cardiac magnetic resonance imaging,’’ J. Amer. Col-
lege Cardiol., vol. 43, no. 11, pp. 2083–2090, Jun. 2004. doi: 10.1016/
j.jacc.2004.01.037.
[3] L. Iles, H. Pfluger, A. Phrommintikul, J. Cherayath, P. Aksit, S. N. Gupta,
D. M. Kaye, and A. J. Taylor, ‘‘Evaluation of diffuse myocardial fibrosis
in heart failure with cardiac magnetic resonance contrast-enhanced T1
mapping,’’ J. Amer. College Cardiol., vol. 52, no. 19, pp. 1574–1580,
Nov. 2008. doi: 10.1016/j.jacc.2008.06.049.
[4] T. Niendorf, D. K. Sodickson, G. A. Krombach, and J. Schulz-Menger,
‘‘Toward cardiovascular MRI at 7 T: Clinical needs, technical solutions
and research promises,’’ Eur. Radiol., vol. 20, no. 12, pp. 2806–2816,
Dec. 2010. doi: 10.1007/s00330-010-1902-8.
[5] C. Santelli, R. Nezafat, B. Goddu, W. J. Manning, J. Smink, S. Kozerke,
and D. C. Peters, ‘‘Respiratory bellows revisited for motion compensa-
tion: Preliminary experience for cardiovascular MR,’’Magn. Reson. Med.,
vol. 65, no. 4, pp. 1097–1102, Apr. 2011. doi: 10.1002/mrm.22687.
[6] R. Millis, Advances in Electrocardiograms: Methods and Analysis.
Norderstedt, Germany: Books on Demand, 2012.
[7] C. Brinegar, Y. J. Wu, L. M. Foley, T. K. Hitchens, Q. Ye, C. Ho, and
Z. P. Liang, ‘‘Real-time cardiac MRI without triggering, gating, or breath
holding,’’ in Proc. 30th Annu. Int. Conf. IEEE Eng. Med. Biol. Soc.,
Aug. 2008, pp. 3381–3384. doi: 10.1109/IEMBS.2008.4649931.
[8] F. Kording, B. Schoennagel, G. Lund, F. Ueberle, C. Jung, G. Adam, and
J. Yamamura, ‘‘Doppler ultrasound compared with electrocardiogram and
pulse oximetry cardiac triggering: A pilot study,’’ Magn. Reson. Med.,
vol. 74, no. 5, pp. 1257–1265, Nov. 2015. doi: 10.1002/mrm.25502.
[9] J. M. Chia, S. E. Fischer, S. A. Wickline, and C. H. Lorenz, ‘‘Per-
formance of QRS detection for cardiac magnetic resonance imaging
with a novel vectorcardiographic triggering method,’’ J. Mag. Reson.
Imag., vol. 12, no. 5, pp. 678–688, Nov. 2000. doi: 10.1002/1522-
2586(200011)12:5<678::AID-JMRI4>3.0.CO;2-5.
[10] D. Stab, J. Roessler, K. O’Brien, C. Hamilton-Craig, and M. Barth, ‘‘ECG
triggering in ultra-high field cardiovascular MRI,’’ Tomography, vol. 2,
no. 3, p. 167, Sep. 2016. doi: 10.18383/j.tom.2016.00193.
[11] G. M. Pohost and K. S. Nayak, Handbook of Cardiovascular
Magnetic Resonance Imaging. Boca Raton, FL, USA: CRC Press,
2006.
[12] A. D. Elster, Questions and Answers in MRI. St. Louis, MO, USA: Wash-
ington Univ. School Med., 2018.
[13] M. S. Nacif, A. Zavodni, N. Kawel, E. Y. Choi, J. A. Lima, and
D. A. Bluemke, ‘‘Cardiac magnetic resonance imaging and its electrocar-
diographs (ECG): Tips and tricks,’’ Int. J. Cardiovasc. Imag., vol. 28, no. 6,
pp. 1465–1475, Aug. 2012. doi: 10S.1007/s10554-011-9957-4.
[14] H. Kugel, C. Bremer, M. Püschel, R. Fischbach, H. Lenzen, B. Tombach,
H. VanAken, andW.Heindel, ‘‘Hazardous situation in theMRbore: Induc-
tion in ECG leads causes fire,’’ Eur. Radiol., vol. 13, no. 4, pp. 690–694,
Apr. 2003. doi: 10.1007/s00330-003-1841-8.
[15] S. Lange and Q. N. Nguyen, ‘‘Cables and electrodes can burn patients
during MRI,’’ Nursing Manage., vol. 36, no. 11, p. 18, Nov. 2006. doi: 10.
1097/00152193-200611000-00012.
[16] J. W. Krug, G. Rose, D. Stucht, G. Clifford, and J. Oster, ‘‘Limita-
tions of VCG based gating methods in ultra high field cardiac MRI,’’
J. Cardiovascular Magn. Reson., vol. 15, no. 1, Jan. 2013, Art. no. W19.
doi: 10.1186/1532-429X-15-S1-W19.
[17] C. J. Snyder, L. DelaBarre, G. J. Metzger, P. F. van de Moortele, C. Akgun,
K. Ugurbil, and J. T. Vaughan, ‘‘Initial results of cardiac imaging at
7 tesla,’’ Magn. Reson. Med., vol. 61, no. 3, pp. 517–524, Mar. 2009.
doi: 10.1002/mrm.21895.
[18] M. Becker, T. Frauenrath, F. Hezel, G. A. Krombach, U. Kremer,
B. Koppers, C. Butenweg, A. Goemmel, J. F. Utting, J. Schulz-Menger, and
T. Niendorf, ‘‘Comparison of left ventricular function assessment using
phonocardiogram- and electrocardiogram-triggered 2D SSFP CINE MR
imaging at 1.5 T and 3.0 T,’’ Eur. Radiol., vol. 20, no. 6, pp. 1344–1355,
Jun. 2010. doi: 10.1007/s00330-009-1676-z.
[19] D. Abi-Abdallah, V. Robin, A. Drochon, and O. Fokapu, ‘‘Alterations in
human ECG due to theMagnetoHydroDynamic effect: A method for accu-
rate R peak detection in the presence of highMHD artifacts,’’ in Proc. 29th
Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., Aug. 2007, pp. 1842–1845.
doi: 10.1109/IEMBS.2007.4352673.
[20] D. W. Chakeres, A. Kangarlu, H. Boudoulas, and D. C. Young, ‘‘Effect of
static magnetic field exposure of up to 8 Tesla on sequential human vital
sign measurements,’’ J. Mag. Reson. Imag., vol. 18, no. 3, pp. 346–352,
Sep. 2003. doi: 10.1002/jmri.10367.
[21] M. Jekic, Y. Ding, R. Dzwonczyk, P. Burns, S. V. Raman, and
O. P. Simonetti, ‘‘Magnetic field threshold for accurate electrocardiog-
raphy in the MRI environment,’’ Mag. Reson. Med., vol. 64, no. 6,
pp. 1586–1591, Dec. 2010. doi: 10.1002/mrm.22419.
[22] M. Schwartz, P. Martirosian, G. Steidle, M. Erb, B. Yang, and F. Schick,
‘‘Feasibility of real-time surface electromyographytriggered diffusion-
weighted imaging for prospective imaging of spontaneous unintentional
focal muscular motion in human calf musculature,’’ in Proc. 34th Annu.
Sci. Meeting Eur. Soc. Magn. Reson. Med. Biol. (ESMRMB), Barcelona,
Spain, Oct. 2017, pp. S83–S84.
[23] A. Babayan et al., ‘‘A mind-brain-body dataset of MRI, EEG, cognition,
emotion, and peripheral physiology in young and old adults,’’ Sci. Data,
vol. 6, Feb. 2019, Art. no. 180308. doi: 10.1038/sdata.2018.308.
[24] M. R. Borich, S. L.Wolf, A. Q. Tan, and J. A. Palmer, ‘‘Targeted neuromod-
ulation of abnormal interhemispheric connectivity to promote neural plas-
ticity and recovery of arm function after stroke: A randomized crossover
clinical trial study protocol,’’ Neural Plasticity, vol. 2018, Feb. 2018,
Art. no. 9875326. doi: 10.1155/2018/9875326.
[25] H. Furby, E. Yhnell, F. Mazzaschi, J. Mole, M. Busse, A. E. Rosser,
and C. Metzler-Baddeley, ‘‘E06 using 3T MRI to explore myelin break-
down in pre-symptomatic huntington’s disease,’’ Tech. Rep., 2018, doi:
10.1136/jnnp-2018-EHDN.100.
[26] Siemens Prisma 3T MRI Scanner User Guide. Ahmanson-Lovelace Brain
Mapping Center, Los Angeles, CA, USA, 2019.
[27] Ceitec, Central Eur. Inst. Technol., Brno, Czechia, 2019.
[28] Multimodal and Functional Imaging Laboratory, Central Eur. Inst. Tech-
nol., Brno, Czechia, 2019.
[29] A. C. Larson, R. D. White, G. Laub, E. R. McVeigh, D. Li, and Simon-
etti, ‘‘Self-gated cardiac cine MRI,’’ Magn. Reson. Med., vol. 51, no. 1,
pp. 93–102, Jan. 2004. doi: 10.1002/mrm.10664.
[30] F. Kording, J. Yamamura, G. Lund, F. Ueberle, C. Jung, G. Adam,
and B. P. Schoennagel, ‘‘Doppler ultrasound triggering for cardiovascular
MRI at 3T in a healthy volunteer study,’’Magn. Reson. Med. Sci., vol. 16,
no. 2, pp. 98–108, Apr. 2017. doi: 10.2463/mrms.mp.2015-0104.
[31] T. Niendorf, L. Winter, and T. Frauenrath, ‘‘Electrocardiogram in an
MRI environment: Clinical needs, practical considerations, safety impli-
cations, technical solutions and future directions,’’ in Advances in
Electrocardiograms-Methods and Analysis. 2012.
[32] S. E. Fischer, S. A. Wickline, and C. H. Lorenz, ‘‘Novel real-time R-
wave detection algorithm based on the vectorcardiogram for accurate
gated magnetic resonance acquisitions,’’ Magn. Reson. Med., vol. 42,
no. 2, pp. 361–370, Aug. 1999. doi: 10.1002/(SICI)1522-2594(199908)
42:2<361::AID-MRM18>3.0.CO;2-9.
[33] L. Axel and M. A. Toms, ‘‘Clinical cardiac magnetic resonance imag-
ing techniques,’’ in Cardiovascular Magnetic Resonance Imaging. 2019,
pp. 17–50. doi: 10.1007/978-1-4939-8841-9_2.
[34] N. Spicher, M. Kukuk, S. Maderwald, and M. E. Ladd, ‘‘Initial evalua-
tion of prospective cardiac triggering using photoplethysmography signals
recorded with a video camera compared to pulse oximetry and electro-
cardiography at 7T MRI,’’ Biomed. Eng. Online, vol. 15, no. 1, p. 126,
Nov. 2016. doi: 10.1186/s12938-016-0245-3.
[35] N. Spicher, ‘‘Cardiac activity measurement from video signals of the
human skin in ultrahigh-field magnetic resonance imaging,’’ Informatik,
vol. 2016, pp. 1–6, 2016.
[36] A. C. Larson, P. Kellman, A. Arai, G. A. Hirsch, E. McVeigh, D. Li, and
O. P. Simonetti, ‘‘Preliminary investigation of respiratory self-gating for
free-breathing segmented cine MRI,’’ Magn. Reson. Med., vol. 53, no. 1,
pp. 159–168, Jan. 2005. doi: 10.1002/mrm.20331.
118626 VOLUME 7, 2019
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
[37] E. Heijman, W. de Graaf, P. Niessen, A. Nauerth, G. van Eys, L. de Graaf,
K. Nicolay, and G. J. Strijkers, ‘‘Comparison between prospective and
retrospective triggering for mouse cardiac MRI,’’ NMR Biomed., vol. 20,
no. 4, pp. 439–447, Jun. 2007. doi: 10.1002/nbm.1110.
[38] X. Hu, T. H. Le, T. Parrish, and P. Erhard, ‘‘Retrospective estimation
and correction of physiological fluctuation in functional MRI,’’ Mag.
Reson. Med., vol. 34, no. 2, pp. 201–212, Aug. 1995. doi: 10.1002/
mrm.1910340211.
[39] G. M. Nijm, A. V. Sahakian, S. Swiryn, J. C. Carr, J. J. Sheehan, and
A. C. Larson, ‘‘Comparison of self-gated cine MRI retrospective car-
diac synchronization algorithms,’’ J. Mag. Reson. Imag., vol. 28, no. 3,
pp. 767–772, Sep. 2008. doi: 10.1002/jmri.21514.
[40] H. Mandelkow, D. Brandeis, and P. Boesiger, ‘‘Good practices in EEG-
MRI: The utility of retrospective synchronization and PCA for the removal
of MRI gradient artefacts,’’ Neuroimage, vol. 49, no. 3, pp. 2287–2303,
2010. doi: 10.1016/j.neuroimage.2009.10.050.
[41] M. Gutberlet, K. Schwinge, P. Freyhardt, B. Spors, M. Grothoff,
T. Denecke, L. Lüdemann, R. Noeske, T. Niendorf, and R. Felix, ‘‘Influ-
ence of high magnetic field strengths and parallel acquisition strategies
on image quality in cardiac 2D CINE magnetic resonance imaging: Com-
parison of 1.5 T vs. 3.0 T.,’’ Eur. Radiol., vol. 15, no. 8, pp. 1586–1597,
Aug. 2005. doi: 10.1007/s00330-005-2768-z.
[42] F. von Knobelsdorff-Brenkenhoff, T. Frauenrath, M. Prothmann,
M. A. Dieringer, F. Hezel, W. Renz, K. Kretschel, T. Niendorf, and
J. Schulz-Menger, ‘‘Cardiac chamber quantification using magnetic
resonance imaging at 7 tesla—A pilot study,’’ Eur. Radiol., vol. 20, no. 12,
pp. 2844–2852, Dec. 2010. doi: 10.1007/s00330-010-1888-2.
[43] T. Frauenrath, F. Hezel, W. Renz, and T. de Geyer d’Orth, M. Dieringer,
F. von Knobelsdorff-Brenkenhoff, M. Prothmann, J. S. Menger, and
T. Niendorf, ‘‘Acoustic cardiac triggering: A practical solution for syn-
chronization and gating of cardiovascular magnetic resonance at 7 tesla,’’
J. Cardiovascular Magn. Reson., vol. 12, no. 1, p. 67, Nov. 2010. doi: 10.
1186/1532-429X-12-67.
[44] R. Hoffmann, S. von Bardeleben, J. D. Kasprzak, A. C. Borges, F. ten Cate,
C. Firschke, S. Lafitte, N. Al-Saadi, S. Kuntz-Hehner, G. Horstick,
C. Greis, M. Engelhardt, J. L. Vanoverschelde, H. Becher, and C. Greis,
‘‘Analysis of regional left ventricular function by cineventriculogra-
phy, cardiac magnetic resonance imaging, and unenhanced and contrast-
enhanced echocardiography: A multicenter comparison of methods,’’
J. Amer. College Cardiol., vol. 47, no. 1, pp. 121–128, Jan. 2006. doi: 10.
1016/j.jacc.2005.10.012.
[45] T. Frauenrath, F. Hezel, U. Heinrichs, S. Kozerke, J. F. Utting, M. Kob,
C. Butenweg, T. Niendorf, and T. Niendorf, ‘‘Feasibility of cardiac gating
free of interference with electro-magnetic fields at 1.5 tesla, 3.0 Tesla and
7.0 tesla using an MR-stethoscope,’’ Investigative Radiol., vol. 44, no. 9,
pp. 539–547, Sep. 2009. doi: 10.1097/RLI.0b013e3181b4c15e.
[46] A. C. S. Brau, C. T. Wheeler, L. W. Hedlund, and G. A. Johnson, ‘‘Fiber-
optic stethoscope: A cardiac monitoring and gating system for magnetic
resonance microscopy,’’ Magn. Reson. Med., vol. 47, no. 2, pp. 314–321,
Feb. 2002. doi: 10.1002/mrm.10049.
[47] F. Tobias, S. Kozerke, F. Henzel, and T. Niendorf, ‘‘The MR-stethoscope:
Safe cardiac gating free of interference with electro-magnetic fields at 1.5
T, 3.0 T and 7.0 T,’’ J. Cardiovascular Mag. Reson., vol. 11, no. 1, 2009,
Art. no. O78. doi: 10.1186/1532-429X-11-S1-O78.
[48] S. G. van Elderen, M. J. Versluis, J. J. Westenberg, H. Agarwal,
N. B. Smith, M. Stuber, A. de Roos, and A. G.Webb, ‘‘Right coronary MR
angiography at 7 T: A direct quantitative and qualitative comparison with
3 T in young healthy volunteers,’’ Radiology, vol. 257, no. 1, pp. 254–259,
Oct. 2010. doi: 10.1148/radiol.100615.
[49] S. Maderwald, S. Orzada, Z. Lin, L. C. Schafer, A. K. Bitz, O. Kraff, and
K. Nassenstein, ‘‘7 tesla cardiac imaging with a phonocardiogram trigger
device,’’ in Proc. Int. Soc. Magn. Reson. Med., Montreal, QC, Canada,
vol. 19, May 2011, p. 1322.
[50] T. Frauenrath, S. Kozerke, P. Boesiger, and T. Niendorf, ‘‘Cardiac gating
free of interference with electro-magnetic fields at 1.5 T, 3.0 T and 7.0 T,’’
inProc. Annu.Meeting Int. Soc. Magn. Reson. Med., Toronto, ON, Canada,
May 2008, p. 207.
[51] K. Nassenstein, S. Orzada, L. Haering, A. Czylwik, M. Zenge, H. Eberle,
T. Schlosser, O. Bruder, E. Müller, M. E. Ladd, and S. Maderwald,
‘‘Cardiac MRI: Evaluation of phonocardiogram-gated cine imaging for
the assessment of global und regional left ventricular function in clini-
cal routine,’’ Eur. Radiol., vol. 22, no. 3, pp. 559–568, Mar. 2012. doi:
10.1007/s00330-011-2279-z.
[52] B. Hiba, N. Richard, M. Janier, and P. Croisille, ‘‘Cardiac and respiratory
double self-gated cine MRI in the mouse at 7 T,’’ Magn. Reson. Med.,
vol. 55, no. 3, pp. 506–513, Mar. 2006. doi: 10.1002/mrm.20815.
[53] J. M. Rubin, J. B. Fowlkes, M. R. Prince, R. T. Rhee, and T. L. Chenevert,
‘‘Doppler US gating of cardiac MR imaging,’’ Academic Radiol., vol. 7,
no. 12, pp. 1116–1122, Dec. 2000. doi: 10.1016/S1076-6332(00)80065-3.
[54] D. A. Feinberg, D. Giese, D. A. Bongers, S. Ramanna, M. Zaitsev,
M. Markl, and M. Gunther, ‘‘Hybrid ultrasound MRI for improved cardiac
imaging and real-time respiration control,’’ Magn. Reson. Med., vol. 63,
no. 2, pp. 290–296, Feb. 2010. doi: 10.1002/mrm.22250.
[55] X. Cheng, H. Li, Y. Chen, B. Luo, X. Liu, W. Liu, H. Xu, and X. Yang,
‘‘Ultrasound-triggered phase transition sensitive magnetic fluorescent nan-
odroplets as a multimodal imaging contrast agent in rat and mouse model,’’
PLoS ONE, vol. 8, no. 12, Dec. 2013, Art. no. e85003. doi: 10.1371/jour-
nal.pone.0085003.
[56] S. Vitek, A. Ezion, and D. Freundlich, U.S. Patent 6 735 461, 2004.
[57] A. Rengle, L. Baboi, H. Saint-Jalmes, R. Sablong, and O. Beuf, ‘‘Optical
cardiac and respiratory device for synchronized MRI on small animal,’’
in Proc. 29th Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., Aug. 2007,
pp. 2046–2049. doi: 10.1109/IEMBS.2007.4352722.
[58] M. Fajkus, J. Nedoma, R. Martinek, V. Vasinek, H. Nazeran, and P. Siska,
‘‘A non-invasive multichannel hybrid fiber-optic sensor system for vital
sign monitoring,’’ Sensors, vol. 17, no. 1, p. 111, Jan. 2017. doi:
10.3390/s17010111.
[59] J. Nedoma, M. Fajkus, M. Novak, N. Strbikova, V. Vasinek, H. Nazeran,
J. Vanus, F. Perecar, and R. Martinek, ‘‘Validation of a novel fiber-
optic sensor system for monitoring cardiorespiratory activities during MRI
examinations,’’ Adv. Elect. Electron. Eng., vol. 15, no. 3, pp. 536–543,
Sep. 2017. doi: 10.15598/aeee.v15i3.2194.
[60] Ł. Dziuda, ‘‘Fiber-optic sensors for monitoring patient physiological
parameters: A review of applicable technologies and relevance to use
during magnetic resonance imaging procedures,’’ J. Biomed. Opt., vol. 20,
no. 1, Jan. 2015, Art. no. 010901. doi: 10.1117/1.JBO.20.1.010901.
[61] J. Nedoma, M. Fajkus, R. Martinek, and V. Vasinek, ‘‘Analysis of non-
invasive FBG sensor for monitoring patient vital signs during MRI,’’ Proc.
SPIE, vol. 10440, Oct. 2017, Art. no. 104400H. doi: 10.1117/12.2277399.
[62] Reconfigurable Embedded Chassis with Integrated Intelligent RealTime
Controller for CompactRIO, document NI cRIO-9072/9073/9074, Nat.
Instrum., Austin, TX, USA.
[63] S. H. Lee, H. C. Kim, and K. S. Jung, ‘‘Atomic force microscopy using
optical pickup head to measure cantilever displacement,’’ Int. J. Precis.
Eng. Manuf., vol. 12, no. 5, pp. 913–915, Oct. 2011. doi: 10.1007/s12541-
011-0122-8.
[64] T. A. Ishola, A. Yahya, A. R. M. Shariff, and S. A. A. Aziz, ‘‘A novel vari-
able rate pneumatic fertilizer applicator,’’ Instrum. Sci. Technol., vol. 42,
no. 4, pp. 369–384, Mar. 2014. doi: 10.1080/10739149.2013.879663.
[65] R. Martinek, J. Brablik, L. Soustek, J. Kolarik, M. Fajkus, J. Nedoma, and
R. Kahankova, ‘‘A comparison of probes based on Bragg grating sensor
and microphones for heart sounds measurement,’’ Proc. SPIE, vol. 10801,
Oct. 2018, Art. no. 108010G. doi: 10.1117/12.2325744.
[66] R. Martinek, R. Kahankova, J. Nedoma, M. Fajkus, and M. Skacel, ‘‘Com-
parison of the LMS, NLMS, RLS, and QR-RLS algorithms for vehicle
noise suppression,’’ in Proc. 10th Int. Conf. Comput. Modeling Simulation,
Jan. 2018, pp. 23–27. doi: 10.1145/3177457.3177502.
[67] C. J. Peters, R. B. Miles, R. A. Burns, P. M. Danehy, B. F. Bathel, and
G. S. Jones, ‘‘Femtosecond laser tagging characterization of a sweeping
jet actuator operating in the compressible regime,’’ in Proc. 32nd AIAA
Aerodyn. Meas. Technol. Ground Test. Conf., Jun. 2016, p. 3248. doi:
10.2514/6.2016-3248.
[68] Datasheet, NI 9250 With BNC, Nat. Instrum., Austin, TX, USA, 2017.
[69] Datasheet, NI 9472, Nat. Instrum., Austin, TX, USA, 2019.
[70] C. Elliott, V. Vijayakumar, W. Zink, and R. Hansen, ‘‘National instru-
ments LabVIEW: A programming environment for laboratory automation
and measurement,’’ J. Assoc. Lab. Automat., vol. 12, no. 1, pp. 17–24,
Feb. 2007. doi: 10.1016/j.jala.2006.07.012.
[71] R.Martinek, R. Kahankova, P. Bilik, J. Nedoma,M. Fajkus, andM. Skacel,
‘‘Speech signal processing using microphones NI 9234 and LabVIEW,’’ in
Proc. 10th Int. Conf. Comput. Modeling Simulation, Jan. 2018, pp. 9–13.
doi: 10.1145/3177457.3177501.
[72] R. Martinek, M. Kelnar, P. Koudelka, J. Vanus, P. Bilik, P. Janku,
H. Nazeran, and J. Zidek, ‘‘A novel LabVIEW-based multi-channel non-
invasive abdominal maternal-fetal electrocardiogram signal generator,’’
Physiol. Meas., vol. 37, no. 2, 238, Feb. 2016. doi: 10.1088/0967-
3334/37/2/238.
VOLUME 7, 2019 118627
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
[73] O. T. Inan, P. F. Migeotte, K. S. Park, M. Etemadi, K. Tavako-
lian, R. Casanella, J. Zanetti, J. Tank, I. Funtova, G. K. Prisk, and
M. Di Rienzo, ‘‘Ballistocardiography and seismocardiography: A review
of recent advances,’’ IEEE J. Biomed. Health Informat., vol. 19, no. 4,
pp. 1414–1427, Jul. 2015. doi: 10.1109/JBHI.2014.2361732.
[74] A. Dinh, Y. Choi, and S.-B. Ko, ‘‘A heart rate sensor based on seismo-
cardiography for vital sign monitoring systems’’ in Proc. 24th Can. Conf.
Elect. Comput. Eng. (CCECE), Niagara Falls, ON, Canada, May 2011,
pp. 665–668. doi: 10.1109/CCECE.2011.6030536.
[75] J. M. Zanetti and K. Tavakolian, ‘‘Seismocardiography: Past, present and
future,’’ in Proc. 35th Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. (EMBC),
Jul. 2013, pp. 7004–7007. doi: 10.1109/EMBC.2013.6611170.
[76] C. A. Wick, O. T. Inan, P. Bhatti, and S. Tridandapani, ‘‘Relation-
ship between cardiac quiescent periods derived from seismocardiog-
raphy and echocardiography,’’ in Proc. 37th Annu. Int. Conf. IEEE
Eng. Med. Biol. Soc. (EMBC), Aug. 2015, pp. 687–690, doi: 10.1109/
EMBC.2015.7318455.
[77] BrainAmp, Operating and Reference Manual for Use in a Laboratory
Environment, Brain Products, 2016.
[78] J. Yao, S. Tridandapani, W. F. Auffermann, C. A. Wick, and P. T. Bhatti,
‘‘An adaptive seismocardiography (SCG)-ECG multimodal framework
for cardiac gating using artificial neural networks,’’ IEEE J. Transl.
Eng. Health Med., vol. 6, Art. no. 1900611, 2018. doi: 10.1109/
JTEHM.2018.2869141.
[79] R. Durichen, K. D. Verma, S. Y. Yee, T. Rocznik, P. Schmidt, J. Bödecker,
and C. Peters, ‘‘Prediction of electrocardiography features points using
seismocardiography data: A machine learning approach,’’ in Proc.
ACM Int. Symp. Wearable Comput., Oct. 2018, pp. 96–99. doi: 10.
1145/3267242.3267283.
[80] M. J. Tadi, E. Lehtonen, T. Koivisto, M. Pänkäälä, A. Paasio, and
M. Teras, ‘‘Seismocardiography: Toward heart rate variability (HRV) esti-
mation,’’ in Proc. IEEE Int. Symp. Med. Meas. Appl. (MeMeA), May 2015,
pp. 261–266. doi: 10.1109/MeMeA.2015.7145210.
[81] R. Martinek, R. Kahankova, J. Jezewski, R. Jaros, J. Mohylova,
M. Fajkus, J. Nedoma, P. Janku, and H. Nazeran, ‘‘Comparative
effectiveness of ICA and PCA in extraction of fetal ECG from
abdominal signals: Toward non-invasive fetal monitoring,’’ Front.
Physiol., vol. 9, p. 648, May 2018, doi: 10.3389/fphys.2018.
00648.
[82] J. M. Bland and D. G. Altman, ‘‘Measuring agreement in method compari-
son studies,’’ Stat.MethodsMed. Res., vol. 8, no. 2, pp. 135–160, Jun. 1999,
doi: 10.1177/096228029900800204.
[83] A. Mittal, A. K. Moorthy, and A. C. Bovik, ‘‘No-reference image quality
assessment in the spatial domain,’’ IEEE Trans. Image Process., vol. 21,
no. 12, pp. 4695–4708, Dec. 2012. doi: 10.1109/TIP.2012.2214050.
[84] A. Mittal, A. K. Moorthy, and A. C. Bovik, ‘‘Referenceless image spatial
quality evaluation engine,’’ in Proc. 45th Asilomar Conf. Signals, Syst.
Comput., vol. 38, Nov. 2011, pp. 53–54.
RADEK MARTINEK was born in Czech Repub-
lic, in 1984. He received the master’s degree in
information and communication technology from
the VSB-Technical University of Ostrava, in 2009.
He has been a Research Fellow, since 2012.
In 2014, he successfully defended his dissertation
thesis titled "The Use of Complex Adaptive Meth-
ods of Signal Processing for Refining the Diag-
nostic Quality of the Abdominal Fetal Electrocar-
diogram." He became an Associate Professor of
Technical Cybernetics, in 2017, after defending the habilitation thesis titled
"Design andOptimization of Adaptive Systems for Applications of Technical
Cybernetics and Biomedical Engineering Based on Virtual Instrumentation."
He has been an Associate Professor at VSB-Technical University of Ostrava,
since 2017. His current research interests include digital signal processing
(linear and adaptive filtering, soft computing—artificial intelligence and
adaptive fuzzy systems, non-adaptive methods, biological signal process-
ing, and digital processing of speech signals); wireless communications
(software-defined radio); power quality improvement. He has published
more than 200 journal and conference articles in his research areas.
JINDRICH BRABLIK was born in 1991. He grad-
uated from the Faculty of Electrical Engineering
and Computer Science, VSB-Technical University
of Ostrava. The field of study was biomedical
technician for bachelor’s studies and information
and control systems for master’s studies. He is
currently pursuing the Ph.D. degree in technical
cybernetics with the VSB-Technical University of
Ostrava, where he focuses on virtual instrumenta-
tion and signal processing of physiological signals.
JAKUB KOLARIK was born in Ostrava, Czech
Republic, in 1992. He received the bachelor’s and
the master’s degrees in control and information
systems from the Department of Cybernetics and
Biomedical Engineering, VSB-Technical Univer-
sity of Ostrava, in 2014 and 2016, respectively.
He is currently pursuing the Ph.D. degree in tech-
nical cybernetics.
MARTINA LADROVA was born in Ostrava,
CzechRepublic, in 1994. She received themaster’s
degree from the Faculty of Electrical Engineering
and Computer Science, VSB-Technical University
of Ostrava, in 2018, where she is currently pursu-
ing the Ph.D. degree. Her research interest includes
digital signal processing, especially biological sig-
nal processing.
JAN NEDOMA was born in Czech Republic,
in 1988. He has been an Assistant Professor at the
VSB-Technical University of Ostrava, since 2016.
His current research interests include fiber-optic
sensors in traffic, civil engineering, and biomed-
ical applications.
RENE JAROS was born in Ostrava, Czech Repub-
lic, in 1992. He graduated from the Faculty of
Electrical Engineering and Computer Science,
VSB-Technical University of Ostrava, in 2015,
where he is currently pursuing the Ph.D. degree
in technical cybernetics. In 2015, he wrote a
Bachelor’s thesis, which deals with transformation
methods of 12-lead ECG to VCG, and in 2017,
he wrote a Diploma thesis, which deals with non-
adaptive methods of fetal ECG signal processing.
His research interest includes fECG extraction by using hybrid methods.
118628 VOLUME 7, 2019
R. Martinek et al.: Low-Cost System for SCG-Based Cardiac Triggering: A Practical Solution
LUKAS SOUSTEK was born in Karvina, Czech
Republic, in 1991. He received the bachelor’s and
the master’s degrees in control and information
systems from the Department of Cybernetics and
Biomedical Engineering, VSB-Technical Univer-
sity of Ostrava, in 2014 and 2016, respectively.
He is currently pursuing the Ph.D. degree in tech-
nical cybernetics.
RADANA KAHANKOVA was born in Opava,
Czech Republic, in 1991. She received the bache-
lor’s and the master’s degrees in biomedical engi-
neering from the Department of Cybernetics and
Biomedical Engineering, VSB-Technical Univer-
sity of Ostrava, in 2014 and 2016, respectively. She
is currently pursuing the Ph.D. degree in technical
cybernetics. Her current research interest includes
improving the quality of electronic fetal monitor-
ing.
MARCEL FAJKUS was born in Czech Republic,
in 1987. He has been an Assistant Professor at
the VSB-Technical University of Ostrava, since
2016. His current research interests include fiber
Bragg sensors and distributed systems in traffic,
civil engineering, and biomedical applications.
LUBOMIR VOJTISEK received the Ph.D. degree
in measurement from the Faculty of Electrical
Engineering and Information Technology, Slovak
Technical University. He is a Researcher and Tech-
nical Specialist Member of the Multi-modal and
Functional Neuroimaging Research Group. He is
currently a Postdoctoral Research Fellow.
PAVLA HANZLIKOVA is currently with the
Clinic of Imaging Methods of Faculty Hospital in
Ostrava and deals with interventional neuroradiol-
ogy, MR spectroscopy, and interventional applica-
tions of 3D image.
PETR KRUPA was born in 1954. He graduated
from the Faculty of Medicine, Masaryk Univer-
sity, Brno. At the Clinic of Imaging Methods of
Faculty Hospital in Ostrava (where he is a Head)
and the Faculty of Medicine, Masaryk Univer-
sity, Brno, deals with interventional neuroradiol-
ogy, MR spectroscopy, interventional applications
of 3D image, and operating simulators.
VOLUME 7, 2019 118629
